Boston Scientific Corporation vs UnitedHealth Group Incorporated — Stock Comparison
Boston Scientific Corporation (BSX) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Boston Scientific Corporation clearly outscores UnitedHealth Group Incorporated on Q·Score (8.5 vs 6.1 out of 10), led by Health (9.1 vs 5.3) and Growth (8.8 vs 5.1). Analyst consensus targets imply greater upside for BSX (+70.2%) than for UNH (+2.2%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.4× debt-to-equity).
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
BSX vs UNH: which stock scores better overall?
Based on Q·Score, Boston Scientific Corporation (BSX) scores 8.5/10 versus UnitedHealth Group Incorporated (UNH) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: BSX or UNH?
Boston Scientific Corporation (BSX) scores higher on Growth (8.8/10 vs 5.1/10). Boston Scientific Corporation reports revenue growth (11.6% YoY) while UnitedHealth Group Incorporated reports (2.0% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is BSX or UNH more attractively valued?
Boston Scientific Corporation (BSX) scores higher on Valuation (8.6/10 vs 6.5/10). BSX trades at 12.2× P/E versus UNH at 19.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about BSX vs UNH?
There are 30 analysts covering BSX with a consensus price target of $77.10, and 26 analysts covering UNH with a consensus target of $409.77. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: BSX or UNH?
Boston Scientific Corporation (BSX) scores higher on Quality (7.7/10 vs 5.9/10). Net profit margin: BSX at 17.3%, UNH at 2.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: BSX or UNH?
Boston Scientific Corporation (BSX) scores higher on Financial Health (9.1/10 vs 5.3/10). Market beta: BSX at 0.56, UNH at 0.65. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of BSX and UNH?
Boston Scientific Corporation (BSX) has a market capitalisation of $67.3B, while UnitedHealth Group Incorporated (UNH) has a market cap of $364.1B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →